港股異動丨阿里巴巴(9988.HK)漲2.41% 加速AIoT及內容生態發展 成立創新中心
格隆匯7月8日丨入選格隆匯2020年“下注中國十大核心資產”名單的阿里巴巴(09988.HK)漲2.41%,報238港元,總市值51079億港元。繼天貓精靈早前宣佈今年投入100億元建立AIoT及內容生態後,阿里巴巴旗下阿里雲IoT、天貓精靈宣佈,聯合成立AIoT創新中心,整合阿里旗下達摩院的技術能力,全面賦能AIoT行業。阿里表示,該創新中心將設立三大創新實驗室,以及質量監控中心,並啟動城市和產業帶的實驗基地規劃,其中,杭州將成為首個示範試點城市,慈溪、嵊州的家電產業帶成為首批規劃基地。新成立的AIoT創新中心會由阿里巴巴集團副總裁庫偉擔任負責人。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.